Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
Phase 4(2)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00243737Phase 2Completed

Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

Role: collaborator

NCT01092351Phase 4Completed

Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults

Role: lead

NCT00978172Phase 4Completed

Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria

Role: lead

NCT00889850Phase 1Completed

Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration

Role: lead

All 4 trials loaded